COFCO Biotechnology Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 9,306.025 million compared to CNY 8,895.459 million a year ago. Operating income was CNY 474.881 million compared to CNY 231.638 million a year ago. Net income was CNY 365.409 million compared to CNY 186.076 million a year ago. Basic earnings per share from continuing operations was CNY 0.1976 compared to CNY 0.1007 a year ago. Diluted earnings per share from continuing operations was CNY 0.1975 compared to CNY 0.1007 a year ago.